CRS+HIPEC in Ovarian Epithelial Cancer (I):
16.1: CRS+HIPEC: Epithelial Ovarian Cancer (FIGO IIIB)
16.2: CRS+HIPEC: Epithelial Ovarian Cancer (FIGO IIIC)
16.3: CRS+HIPEC: Epithelial Ovarian Cancer (FIGO IV)
16.4: CRS+HIPEC: peritoneal recurrence of Epithelial Ovarian Cancer
16.5: Primary surgical treatment of advanced borderline ovarian cancer
16.6: CRS+HIPEC: peritoneal recurrence of “borderline” ovarian cancer
CRS+HIPEC in other gynecologic tumors (II):
16.7: CRS+HIPEC in peritoneal recurrence of Endometrial Cancer (surgery and previous RDT)
16.8: CRS+HIPEC in Peritoneal Recurrence of Primary Peritoneal Serous Carcinoma
16.9: CRS+HIPEC in peritoneal recurrence of Mucinous Endocervical Adenocarcinoma
16.10: CRS+HIPEC in uterine sarcoma
16.11: CRS+HIPEC in Peritoneal Recurrence of Immature Teratoma (G2)